|
Expression-Based Multi-Gene Signatures for CRC Recurrence and Chemoselection
|
5R44CA119565-06
|
$999,610
|
$999,610
|
Sears, Christopher
|
AMBERGEN, INC
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
5U01CA098710-08
|
$288,303
|
$288,303
|
GAPSTUR, SUSAN
|
AMERICAN CANCER SOCIETY, INC.
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-05S1
|
$75,000
|
$2,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-05
|
$2,934,758
|
$88,043
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genomic Approaches to Defining Inherited Basis of Childhood Cancer
|
5R01CA138836-02
|
$595,269
|
$595,269
|
PLON, SHARON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Familial and Early Onset Colorectal Cancer
|
5R01CA072851-16
|
$332,512
|
$332,512
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
The pVHL/Jade-1/beta-catenin axis in renal cancer
|
5R01CA079830-10
|
$320,196
|
$320,196
|
COHEN, HERBERT
|
BOSTON MEDICAL CENTER
|
|
Biochemical Markers in the Nurses? Health Study Cohort
|
5U01CA049449-22
|
$1,115,005
|
$892,004
|
Hankinson, Susan
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes
|
5K07CA120448-05
|
$141,548
|
$141,548
|
STOFFEL, ELENA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Validation of Genomic Targets in Melanoma
|
2R01CA114337-07A1
|
$370,543
|
$370,543
|
KASHANI-SABET, MOHAMMED
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S1
|
$73,029
|
$730
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S2
|
$50,000
|
$500
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-22
|
$4,849,180
|
$48,492
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Identification of Significant Race Associated Colon Cancer Drive Gene Mutations
|
1R21CA149349-01A1
|
$273,180
|
$136,590
|
WILLIS, JOSEPH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Validation of copy number changes by MLPA as predictors of relapse in Wilms tumor
|
1R21CA155556-01
|
$191,835
|
$191,835
|
PERLMAN, ELIZABETH
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
An Integrated System for Image-Guided Radiofrequency Ablation of Liver Tumors
|
7R01CA124377-05
|
$343,716
|
$171,858
|
CLEARY, KEVIN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
DICER1 and the Pleuropulmonary Blastoma Family Cancer Syndrome
|
5R01CA143167-02
|
$331,914
|
$331,914
|
Hill, Dana
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-20
|
$258,854
|
$258,854
|
BIEGEL, JACLYN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Cytogenetic and Molecular Studies of Chromosome 22
|
5R01CA039926-23
|
$366,215
|
$366,215
|
EMANUEL, BEVERLY
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-04
|
$625,023
|
$625,023
|
MARIS, JOHN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
THE PATHOGENESIS OF DYSKERATOSIS CONGENITA
|
5R01CA106995-07
|
$313,388
|
$313,388
|
MASON, PHILIP
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
5R01CA140198-03
|
$331,098
|
$165,549
|
Mosse, YAEL
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Cancer Center Support Grant
|
3P30CA033572-28S1
|
$91,911
|
$1,838
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-28S2
|
$75,000
|
$1,500
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-28S3
|
$139,999
|
$2,800
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-28
|
$2,225,352
|
$44,507
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CpG methylation and mutation
|
5R01CA084469-12
|
$283,061
|
$283,061
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA013696-38
|
$3,816,425
|
$152,657
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-38S1
|
$74,998
|
$3,000
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-38S2
|
$139,995
|
$5,600
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
AIDS Associated Lymphoproliferative Disorders
|
5R37CA037295-28
|
$390,425
|
$390,425
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Assessment of Inherited Colon Cancer Prediction Models in Diverse Populations
|
5K07CA151769-02
|
$171,180
|
$171,180
|
Kastrinos, Fay
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A pilot study of statin therapy and risk of malignant glioma
|
5K07CA127468-04
|
$135,513
|
$67,757
|
Lai, Rose
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Naphthalene exposure, chromosomal aberrations in poor urban school children.
|
1U01CA159157-01
|
$209,018
|
$209,018
|
ORJUELA, MANUELA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Genes, environment and breast cancer risk: The 15 year follow-up of the Prof-SC
|
1R01CA159868-01A1
|
$2,081,492
|
$2,081,492
|
TERRY, MARY BETH
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S5
|
$11,164,583
|
$334,937
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S6
|
$75,000
|
$2,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
High-throughput oncogene mutation detection in human cancer
|
5R33CA126674-04
|
$315,153
|
$315,153
|
GARRAWAY, LEVI
|
DANA-FARBER CANCER INSTITUTE
|
|
DF/HCC SPORE in Prostate Cancer
|
5P50CA090381-10
|
$2,185,000
|
$895,850
|
KANTOFF, PHILIP
|
DANA-FARBER CANCER INSTITUTE
|
|
High-throughput technology that enables sequencing depth for colorectal CA
|
1R21CA151164-01A1
|
$131,001
|
$131,001
|
Makrigiorgos, G.
|
DANA-FARBER CANCER INSTITUTE
|
|
The Genetics and Prevention of Gastrointestinal Cancers
|
5K24CA113433-07
|
$196,416
|
$196,416
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
|
Validation and extension of the PREMM Model for mismatch repair gene mutations
|
5R01CA132829-04
|
$379,100
|
$94,775
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INSTITUTE
|
|
Brain Tumors - Immunological and Biological Studies
|
5R37CA011898-41
|
$682,341
|
$682,341
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Adherence to Cancer Risk Management Among Unaffected BRCA1/2Mutation Carriers
|
1R03CA157212-01A1
|
$84,838
|
$84,838
|
Buchanan, Adam
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-37S1
|
$37,988
|
$2,279
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-37
|
$5,723,821
|
$343,429
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Young Smoker's Reactions to Genetic Risk for Lung Cancer
|
5R01CA121922-05
|
$192,611
|
$192,611
|
LIPKUS, ISAAC
|
DUKE UNIVERSITY
|
|
Atlantic Breast and Gynecologic Clinical Validation Center
|
5U01CA084955-12
|
$498,270
|
$498,270
|
Marks, Jeffrey
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-37S2
|
$75,000
|
$4,500
|
MEANS, ANTHONY
|
DUKE UNIVERSITY
|
|
Emory Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-03S1
|
$48,306
|
$1,932
|
Curran, Walter
|
EMORY UNIVERSITY
|
Total relevant funding to Genetic Testing for this search: $102,522,607
|